• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

LCNTDR & The HAT Platform Scientific Research Meeting

1-3 February 2022

Online webinar

The London Centre for Neglected Tropical Disease Research, the HAT Platform, and RSTMH are co-hosting a series of scientific research roundtable meetings to convene global researchers who are working to interrupt the transmission and elimination of HAT as a public health problem, or whose work in a related area who could contribute to the effort.

Roundtable meetings

Developments in diagnostics, surveillance, treatment and vector control and the gaps in research that if filled could support the HAT elimination effort in 2022 and beyond

Date: Tuesday, 1 February 2022
Time: 13:00 – 15:00 GMT

Facilitator: Gerardo Priotto, WHO

Confirmed panelists include:  

  • Philippe Büscher, Institute of Tropical Medicine Antwerp 
  • Stephen Torr, Liverpool School of Tropical Medicine  
  • Deirdre Hollingsworth, NTD Modelling Consortium, Big Data Institute, University of Oxford
  • Wilfred Mutombo, Clinical Project Leader and Medical Manager, DNDi

Social sciences and operational research advances and further needs.

Date: Wednesday, 2 February 2022
Time: 13:00 – 15:00 GMT

Facilitator: Jennifer Palmer, London School of Hygiene and Tropical Medicine 

Confirmed panelists include: 

  • Salome Bukachi, University of Nairobi 
  • Charlie Kabanga, freelance social scientist  
  • Ann Kelly, Kings College London 
  • Catiane Vander Kelen, Institute of Tropical Medicine Antwerp 

Summary of the points made and discussed in the previous meetings and to the priorities that have emerged

Date: Thursday, 3 February 2022
Time: 13:00 – 15:00 GMT

Confirmed panelists include: 

  • Simon Croft, London School of Hygiene and Tropical Medicine 
  • Paulo Macana, Institute for Combat and Control of Trypanosomiasis, Angola 
  • Florent Mbo, Access Leader, DNDi-HAT Platform DRC 
  • José Ramón Franco, WHO 

Presentations

Ethnographic study on HAT in DRC: Applying an ecological model to understand contributory factors to community engagement in HAT control in 14 endemic health zones
Charlie Kabanga, Freelance Social Scientist and International Development Practitioner, UK
Vector control and sleeping sickness: Contributions of insecticide-based methods to HAT elimination goals
Inaki Tirados and Andrew Hope, Liverpool School of Tropical Medicine, UK
Advances and next steps in the modelling of HAT
Kat Rock on behalf of the HAT MEEP team, The University of Warwick, UK
Sleeping sickness disease control in the DRC: Out of pocket expenses and impact
Rian Snijders, Institute of Tropical Medicine Antwerp, Belgium
DNDi development of NECT, fexinidazole and acoziborole -HAT elimination drive
Olaf Valverde Mordt, Clinical Project Leader (HAT), DNDi, Switzerland
Modelling the impact of fexinidazole use on HAT transmission in the DRC
Mimi Das, Swiss Tropical Public Health, Switzerland
Re-emergence of HAT in Bangassou, Central African Republic
Romaric Nzoumbou-Boko, Parasitology & Immunology, Institut Pasteur de Bangui
Support to HAT elimination agenda in DRC
Raquel Inocêncio da Luz, Institue of Tropical Medicine Antwerp, Belgium
Health work and skills in the last mile of disease elimination
Jean-Benoît Falissse, Edinburgh University
Are there still/again HAT cases in Dingila?
Erick Mwamba Miaka, Directeur, Programme National de Lutte contre la THA, DRC

View all presentations

More information

  • Event website and registration

Sleeping sickness

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License